Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/23999
Başlık: Is glucocorticoid-induced osteonecrosis after kidney transplantation related to osteoporosis?
Yazarlar: Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji ve Metabolizma Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Radyoloji Anabilim Dalı.
0000-0002-0710-0923
0000-0001-7482-668X
Ersoy, Alparslan
Kahvecioğlu, Serdar
Ersoy, Canan
Akdağ, İbrahim
Yurtsever, İsmail
Dilek, Kamil
AAH-5054-2021
AAH-8861-2021
35612977100
55956719500
6701485882
8342488100
8535041400
56005080200
Anahtar kelimeler: Transplantation
Urology & nephrology
Kidney transplantation
Kidney failure, chronic
Humans
Glucocorticoids
Femur head necrosis
Female
Yayın Tarihi: May-2006
Yayıncı: Oxford University Press
Atıf: Ersoy, A. vd. (2006). ''Is glucocorticoid-induced osteonecrosis after kidney transplantation related to osteoporosis?''. Nephrology Dialysis Transplantation, 21(5), 1452-1453.
Özet: Osteopenia and osteonecrosis (ON) cause important longterm morbidity in renal transplant (Tx) recipients with increasing incidences because of longer graft survival and related drug exposure. A 38-year-old woman who started on haemodialysis in November 2001 had a renal Tx from a live relative in March 2003 due to chronic pyelonephritis with vesicoureteral reflux related end-stage renal disease. She had persistent secondary amenorrhoea 2 months before dialysis treatment. Throughout this period she had calcitriol and phosphorus binders for controlling secondary hyperparathyroidism. Her pre-Tx serum parathyroid hormone (PTH) was 73.2 pg/ml and body mass index (BMI) was 18.4 kg/m2 . Post-Tx immunosuppressive treatment was prednisolone (500 mg initially, then 30 mg/day), tapered to 25 mg/day by postoperative day 14, mycophenolate mofetil (2 g/day), cyclosporin (CsA; 100 mg/d) and daclizumab (a dose of 1 mg/kg, totalling five dosages with 2-week intervals). After an uneventful 4 weeks she complained of severe leg pain and symptoms of muscle weakness in the previous 4 days. The dose of prednisolone was tapered to 15 mg/day, but pain developed in both shoulders. Diffuse ON was diagnosed by hip and shoulder magnetic resonance imagings (MRI). At the time of diagnosis the total cumulative doses of prednisolone and CsA were 1220 mg and 2925 mg in 4 weeks, respectively. Serum creatinine was 0.7 mg/dl, calcium 10.5 mg/dl, Alkaline phosphatase (ALP) 271 IU/l, PTH 84 pg/ml, calcitonin 27 pg/ml and calcitriol 22.9 ng/dl. Bone mineral densities (BMD) of the lumbar spine and the hip region by Dual x-ray absorptiomtery (DEXA) after post-Tx 8 weeks were evaluated as osteoporosis with T scores of 3.2 and 3.9, respectively. Oral calcium, calcitriol and alendronate were added to the treatment. Her complaints regressed within 10 days. The dose of prednisolone was tapered to 10 mg/day at month 4 and to 5 mg/day at month 10. One year later, hip and shoulder MRIs showed normal findings. The respective post-Tx T scores of the lumbar spine and the femoral neck improved from -2.8 and -3.5 in the first year to -2.4 and -2.2 in the second year. Her serum creatinine level was 0.8 mg/dl with no complaint.
URI: https://doi.org/10.1093/ndt/gfi342
https://academic.oup.com/ndt/article/21/5/1452/1822097
http://hdl.handle.net/11452/23999
ISSN: 0931-0509
Koleksiyonlarda Görünür:Web of Science

Bu öğenin dosyaları:
Dosya Açıklama BoyutBiçim 
Ersoy_vd_2006.pdf180.07 kBAdobe PDFKüçük resim
Göster/Aç


Bu öğe kapsamında lisanslı Creative Commons License Creative Commons